CSL Limited
Jenis perusahaan | Umum |
|---|---|
| Kode emiten | ASX: CSL |
| Industri | Bioteknologi |
| Didirikan | 1916 (Departemen pemerintah federal), 1994 (privasi) |
| Kantor pusat | Parkville, Melbourne, Victoria, Australia[1] |
Tokoh kunci | Paul Perreault (CEO) |
| Produk | Plasma darah, vaksin, antivenom, laboratorium, dan produk medis lainnya |
| Pendapatan | |
Karyawan | 25,000 person (2019)[1] |
| Divisi |
|
| Situs web | www |
CSL Limited adalah perusahaan bioteknologi khusus global yang meneliti, mengembangkan, memproduksi, dan memasarkan produk untuk merawat dan mencegah kondisi medis manusia yang serius. Area produk CSL termasuk turunan plasma darah, vaksin, antivenom, dan reagen kultur sel yang digunakan dalam berbagai penelitian medis dan genetik serta aplikasi manufaktur.[2]
Catatan kaki
- ^ a b c d "Annual Report 2019" (PDF). CSL Limited. 2019.
- ^ "CSL LTD (CSL:ASX): Stock Quote & Company Profile - Businessweek". businessweek. Diarsipkan dari asli tanggal 18 January 2013. Diakses tanggal 1 September 2020.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.